What I tell clients about Hashimoto's.

A few times a month, someone books an intake with me and the first thing they say, before I've asked anything, is: "I have Hashimoto's."

Sometimes they were diagnosed by an endocrinologist. Sometimes by a primary-care doctor who ran a single test. More and more often lately, they were told by another practitioner that the symptoms they're describing must be Hashimoto's. They've been on Synthroid for two years, or they're considering starting it, or they're convinced their fatigue, weight gain, and brain fog must come from this.

That said, here is what I see, and the questions I encourage clients to take back to their physician.

Why so many people are walking around with this label

Hashimoto's the disease has not gotten more common at the rate the label has. A few reasons.

The symptoms are non-specific. Fatigue, weight gain, brain fog, hair thinning, cold hands, low mood. Those describe Hashimoto's, but they also describe perimenopause, iron deficiency, sleep apnea, depression, chronic stress, post-viral syndromes, and the ordinary wear-and-tear of being a working adult in 2026. Pattern-matching on symptoms alone is not how thyroid disease is diagnosed in the medical literature, but in practice, sometimes it is.

Antibody testing has gotten cheaper and more accessible. Direct-to-consumer labs and functional-medicine clinics test for TPO antibodies routinely. Once a slightly elevated antibody value is on paper, "you have Hashimoto's" sometimes follows, even when the rest of the picture doesn't support it.

And subclinical thyroid changes are sometimes treated as full disease. Here's the number I keep coming back to:

Twenty-one million people. On a medication. They probably don't need.

That stat alone changed how I run intakes. Not because I'm trying to take anyone off their medication (that is a conversation for them and their prescriber), but because it gave me a clearer sense of how often the diagnostic picture deserves a second look from the patient's own physician.

What Hashimoto's actually is

Hashimoto's thyroiditis is an autoimmune condition. The immune system makes antibodies, primarily against thyroid peroxidase (TPO) and sometimes thyroglobulin, and those antibodies slowly damage the thyroid gland's ability to produce hormone.

The disease has stages. In the earliest, antibodies are present but the gland is keeping up. TSH and free T4 look normal, and many people have few or no symptoms for years. Eventually, in some patients, TSH starts to rise (subclinical hypothyroidism), and finally, sometimes, overt hypothyroidism, where TSH is clearly elevated and free T4 has dropped.

The disease can move fast or slow, and it can also stabilize for years at any stage. A positive antibody result is not a sentence. It's a signal worth investigating, not a verdict.

What the literature says about how Hashimoto's is diagnosed

In the medical literature, a Hashimoto's diagnosis is described as the convergence of three things, not one.

1. Antibodies

TPO antibodies are present in roughly 95 percent of Hashimoto's patients. Thyroglobulin antibodies in 60 to 80 percent. About 10 to 15 percent of biopsy-confirmed Hashimoto's cases are seronegative (antibodies absent or low), and tend to be milder forms.

The reverse is what most people don't hear. Elevated TPO antibodies can also occur in healthy people, in other autoimmune conditions, and in transient post-viral states without thyroid disease being present. In my opinion, an isolated positive antibody is a yellow flag, not a finished story.

2. A clinical pattern

Symptoms have to fit thyroid dysfunction (fatigue, cold intolerance, weight changes, hair thinning, slow reflexes, menstrual changes), and ideally there should be either current or progressing biochemical evidence: a TSH outside the functional range, a declining free T4, a rising reverse T3.

3. Imaging when needed

Thyroid ultrasound shows a diffusely heterogeneous, hypoechoic gland in active Hashimoto's. It's not always required, but it can resolve ambiguous cases. The histologic gold standard, biopsy showing lymphocytic infiltration, is rarely necessary outside of nodule investigation.

The full picture is what the literature describes as the diagnostic standard. A single antibody value, on a single day, with no symptom workup or trend data, isn't enough by that standard. Even when it's labeled that way.

What I tell clients about Synthroid

Levothyroxine (Synthroid is the most common brand) is a synthetic form of T4. It works. For people with overt hypothyroidism, it is a safe, well-studied, often life-changing medication. The medication itself is not the problem. What I find worth asking about, in my opinion as a non-prescriber, is who is being put on it, whether the workup was complete, and whether they are being monitored after.

About 25 percent of patients on levothyroxine are described in the literature as overtreated (their dose is higher than they need), and overtreatment carries real costs that, in my view, clients deserve to know about.

• Bone density loss. Long-term overtreatment, especially in postmenopausal women, is associated in long-running observational data with accelerated bone loss and increased fracture risk. Rarely part of the initial conversation about starting the medication, but it matters.
• Cardiac arrhythmias. Atrial fibrillation is the most common arrhythmia associated with levothyroxine overtreatment, particularly in patients over 65. Cardiac wall thickness can also increase.
• Anxiety, palpitations, tremors, heat intolerance. The classic running hot symptoms. In my view, these are often worth raising with a prescriber to ask whether the dose is right.
• Hair loss, insomnia, fatigue. Counterintuitively, levothyroxine can produce the same symptoms it was prescribed to fix when the dose is wrong, the form is wrong (some people don't convert T4 to T3 well), or absorption is being interfered with.
• Drug and food interactions. Calcium, iron, magnesium, coffee, soy, fiber, and many medications interfere with absorption. Most clients I see have never been told to take it on an empty stomach with water and wait 30 to 60 minutes before anything else. If your prescriber didn't mention this, in my opinion it's worth asking about.

The deeper issue I see: most people prescribed levothyroxine are never re-evaluated. The follow-up TSH that should happen at 6 to 8 weeks often doesn't. Dosing needs change with weight, age, pregnancy, and menopause. A dose that was right at 35 may not be right at 45.

None of that is a recommendation to stop, change, or skip your medication. It is a list of questions I encourage clients to bring back to their prescriber.

The symptoms, and what they get confused with

Hashimoto's symptoms overlap with a long list of other conditions. The pattern the literature describes as more characteristic tends to be slow, progressive onset over months to years. Not "I felt fine last month and now I don't." Plus a few that are more specific:

• Cold intolerance that's new for you
• Hair thinning at the outer third of the eyebrows (a classic if not universal sign in the literature)
• Persistent muscle aches not explained by activity
• Slow Achilles reflex (easy for a clinician to test, rarely tested)
• Dry skin, brittle nails, slow wound healing
• Constipation that's new or worsening

What I see Hashimoto's get confused with, and what I encourage clients to verify with their physician before accepting it as the only explanation:

• Iron-deficiency anemia. Same fatigue, same hair thinning, same cold intolerance. Most workups check hemoglobin and stop. Ferritin tells the fuller story.
• Vitamin D deficiency. Same fatigue, same low mood, same diffuse aches.
• Perimenopause. Same brain fog, same sleep disruption, same weight redistribution. Often overlaps with thyroid changes. Both can be true at once.
• Sleep apnea. Underdiagnosed in women, and in my opinion responsible for a lot of I'm tired all the time that gets pinned on the thyroid.
• Chronic stress and HPA-axis dysregulation. In my view, the most under-credited cause of thyroid-like symptoms in adults under 50.
• Post-viral syndromes. More common since 2020. They can transiently elevate antibodies and depress thyroid function in ways that resolve without intervention.

The point isn't that Hashimoto's isn't real. It is. The point I want clients to walk away with is that the workup the literature describes is wider than a single antibody test, and in my experience, it's worth asking your physician to widen it.

What the research says about non-medication support

There is a wide gap between what the wellness industry claims you can do for Hashimoto's and what the peer-reviewed evidence supports. Here is a summary of what the research backs, with numbers attached. None of this is a substitute for working with a licensed provider. It is information I share with clients so they can make informed decisions in partnership with their medical team.

Selenium

This is the single best-supported nutritional intervention in the literature. A 2024 meta-analysis in Thyroid (29 cohorts, 2,358 participants) showed selenium supplementation significantly reduced TPO antibodies at both 3 and 6 months, in patients on and off thyroid medication. Effective range described in the trials: 80 to 200 mcg per day, with some studies going up to 400 mcg. Safety is generally good in this range. Higher long-term doses carry their own risks. This is not more is better.

Vitamin D

Vitamin D deficiency (25(OH)D under 20 ng/mL) is associated with TPO antibody levels 40 to 60 percent higher than in vitamin-D-replete patients. Supplementation at 2000 to 4000 IU per day is associated with antibody reductions of 15 to 30 percent, with the effect concentrated in patients who started deficient. Already-replete patients see less benefit. Test before supplementing, and let your physician advise on a target level based on your history.

Myo-inositol plus selenium

Better-studied than most people realize. In a randomized trial of 168 patients with TSH between 3 and 6 and elevated TPO antibodies, the combination of 600 mg myo-inositol plus 83 mcg selenium daily outperformed selenium alone, significantly lowering TSH, reducing antibodies, and raising T3 and T4. Multiple subsequent trials and a 2024 meta-analysis confirm the combination outperforms selenium alone in subclinical Hashimoto's.

Gluten elimination

Honest summary: the evidence is mixed and the overall certainty is low. Some randomized trials in non-celiac Hashimoto's patients show meaningful antibody reductions. One widely-cited trial showed a 24 percent drop in TPO and Tg antibodies at six months on a strict gluten-free diet. Others show no effect or mixed results. Where it works, it tends to work in patients with subclinical celiac, gluten sensitivity, or measurable gut permeability. A 60 to 90 day strict trial, with antibody testing before and after, is in my opinion the most direct way to know whether it matters for you specifically. Worth a conversation with your physician.

Gut healing

The gut-thyroid axis is a real area of research. Chronic dysbiosis, intestinal permeability, and untreated infections (H. pylori, SIBO) have been associated in the literature with worse Hashimoto's outcomes. Working on gut health doesn't cure the disease. In my opinion, it removes one of the chronic immune triggers worth addressing.

Stress, sleep, HPA-axis support

Cortisol dysregulation suppresses T4-to-T3 conversion in the literature, and worsens autoimmune activity. Sleep restriction does the same. The interventions are unglamorous. In my experience working with clients, they often determine whether a supplement protocol moves antibodies at all.

Nutrient repletion

Iron (specifically ferritin), zinc, magnesium, B12. All required for healthy thyroid function and conversion. Depletion in any of these can blunt every other intervention. Test, don't guess. Your physician or a holistic practitioner can help you read the panel.

Where the genes come in

This is where a tuned protocol stops looking like a generic one. The same supplement at the same dose lands very differently in two different bodies, and the genetic patterns that drive that difference are testable.

The patterns I look at first when working with Hashimoto's clients:

• MTHFR. Methylation efficiency. Reduced activity often means the body uses methylated forms of folate and B12 more efficiently than the synthetic versions on the supplement aisle. In my experience, mismatch here is one of the most common reasons clients tell me "I tried a B-complex and felt worse."
• VDR. Vitamin D receptor activity. Patients with VDR variants often need higher doses of vitamin D to reach the same tissue effect, even when serum levels look fine.
• COMT. Catecholamine and estrogen clearance. In my experience, slow COMT plus chronic stress plus estrogen dominance is a common Hashimoto's setup, particularly in women in perimenopause. Slow COMT also affects supplement tolerance. Methyl donors that work for one body can overstimulate another.
• GST and GPX. Glutathione recycling. Variants here suggest a higher need for sulfur-rich foods, NAC, or supplemental glutathione to keep up with autoimmune oxidative load.

None of this changes whether you have Hashimoto's. It changes what your protocol can look like once a diagnosis is confirmed by your physician.

The reason supplementation should match what your body actually needs, not what's popular or what you heard about, is that Hashimoto's is the diagnosis where miscalibration causes the most harm. Iodine without selenium. Folic acid (synthetic) instead of methylfolate. Vitamin D without K2. Each of those is somebody on a wellness blog. Each of them, in my opinion, can make Hashimoto's worse.

When medication is generally indicated (a question for your prescriber, not me)

I want to be precise here, because the anti-medication wellness narrative has, in my opinion, caused real harm. The decision about whether you need Synthroid, or a different dose, or a different formulation, is between you and your prescriber. What I can offer is a summary of what the literature describes.

Levothyroxine is generally indicated when there is overt hypothyroidism (TSH clearly elevated, free T4 below range). The risks of untreated overt hypothyroidism (cardiovascular disease, cognitive decline, infertility, myxedema in severe cases) are higher than the medication's risks. It is also generally indicated in pregnancy, or trying to conceive with antibody-positive thyroid disease, where even subclinical hypothyroidism increases miscarriage risk and the case for treatment is well-established.

It is generally seen as less straightforward in the literature when:

• TSH is mildly elevated on a single test with normal free T4 and there has been no retest at 8 to 12 weeks
• Antibodies are positive but there is no clinical or biochemical hypothyroidism
• Lifestyle and supplementation interventions haven't been trialed for an adequate window
• Symptoms could plausibly be explained by something else that hasn't been ruled out

These are conversations to bring to your prescriber.

If you are already on Synthroid and wondering whether you still need it: please do not stop on your own. Stopping abruptly can cause real cardiovascular and metabolic stress. The right move, in my opinion, is to ask your prescriber for a current TSH, free T4, and free T3 panel, and to bring up that you'd like to revisit whether the dose is still right.

A note on what we're actually doing here

The reason I encourage clients to take a closer look at their Hashimoto's diagnosis isn't because I doubt the disease. It's because, in my opinion, the cost of a wrong fit (years on a medication that may not help and may quietly cause harm) is real. And it's real for women in particular, since they carry most of the prescriptions and most of the bone-density and cardiac risk that follow.

A complete medical workup, in my view, deserves a complete picture. A protocol works best when it is tuned to the actual person, not the average patient. And a medication strong enough to alter cardiac function and bone density, in my opinion, deserves more than a single lab and a refill button.

That's what I tell clients. That's the work.

This is one practitioner's opinion and a summary of public research. It is educational, not medical advice. Diagnosis and pharmaceutical management belong with a licensed physician. The Integrative Wellness practice works alongside your medical team, not in place of one. Do not change a thyroid medication dose without your prescriber's involvement.